Market Research Reports, Inc. has announced the addition of “PharmaPoint: Hemophilia A and B - Global Drug Forecast and Market Analysis to 2022” research report to their offering. Inquire about this report: http://goo.gl/gDomS2

1. Category : Pharma & Healthcare
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com

2. Introduction to Report
§ Launch Date: November 30, 2013
§ Number of Pages: 306
§ Geography Coverage: Global
§ Available Format: PDF
§Price For Single User License: USD 9,995
§Price For Site License: USD 19,990
§Price For Global User License: USD 29,985
§Delivery Time: Within 24 Hours (During Working Days)
www.MarketResearchReports.com

3. About the Report
The competitive landscape of hemophilia A and B
recombinant therapy in the US and 5EU is dominated by
the use of recombinant FVIII and FIX replacement factors,
and patients with severe forms of the disease receive
frequent prophylactic infusions beginning from the first
one or two years of life and often continuing through
adulthood. However, the burden on patients and their
families to maintain the prophylactic treatment schedule
is high, and there is a significant unmet need for new
therapies that can reduce the number of weekly
prophylactic infusions and alleviate some of this
treatment burden.
www.MarketResearchReports.com

4. Research Findings
§Overview of hemophilia A and B, including epidemiology,
etiology, symptoms, diagnosis, pathology and treatment
guidelines.
§Annualized hemophilia A and B (including inhibitor patients)
therapeutics market revenue, annual cost of therapy and
treatment usage pattern data by patient segment forecast from
2012 to 2022.
§Key topics covered include strategic competitor assessment,
market characterization, unmet needs, clinical trial mapping and
implications for the hemophilia therapeutics market
§Pipeline analysis: The hemophilia pipeline is robust, with many
late-stage candidates set to launch in the forecast period. The
most promising 12 candidates in Phase III development are
highlighted and profiled.
§Analysis of the current and future market competition in the
global hemophilia A and B markets, including insightful review of
the key industry drivers, restraints and challenges. Each trend is
independently researched to provide qualitative analysis of its
implications.
www.MarketResearchReports.com

5. Research Findings Continues..
§Market Model Features
§An interactive excel forecast model based on primary
research interviews and surveys with KOLs and highprescribing physicians is included in this report*. This
patient based model provides diagnosis rates, patient
segmentation, treatment rates, annual costs of therapy ,
and indication-specific drug sales for the 10 year forecast
period. The forecast model is robust, fully transparent,
and easy to navigate. Moreover, our models support data
presented in the reports and the complete methodology
is outlined in the report and the model.
www.MarketResearchReports.com

6. Report Highlights:
§Number of Pages – 306
§Number of Tables – 127
§Number of Figures – 24
§Number of Companies Mentioned – 10
§Number of Marketed Drugs Mentioned – 7
§Pipeline Drugs Mentioned – 12 Phase III drugs; 11 Phase I/II
§Companies Profiled – Baxter, Biogen Idec, Novo Nordisk, CSL
Behring, Bayer, Pfizer
§Markets Covered – US, France, Germany, Italy, Spain, UK, Japan,
Argentina and China
§Hemophilia A and B Patient Segmented by Method of Therapy
– On-demand or prophylactic
§Patients with Inhibitors Segmented Separately
www.MarketResearchReports.com

7. Report Coverage
1. Table of Contents
2. Introduction
3. Disease Overview
4. Epidemiology
5. Disease Management
6. Competitive Assessment
7. Opportunity and Unmet Need
8. Pipeline Assessment
9. Current and Future Players
10.Market Outlook
11.Appendix
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com

8. Company Coverage
For more details regarding company coverage and TOC see the last slide
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com

9. Custom Research:
§ Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let
us know your specific research requirements. Our goal
is to cater to your requirements be it for a custom
market research project, syndicated research report on
a specific market or industry sector, newsletter creation,
case study development or anything else related to
marketing research.
For Any Customization Related query Visit IdeaCenter @
http://www.marketresearchreports.com/idea-center
www.MarketResearchReports.com

10. How To Buy This Report?
Visit following URL to see Table of Content and
purchase this publication:
http://www.marketresearchreports.com/globaldata/phar
mapoint-hemophilia-and-b-global-drug-forecast-andmarket-analysis-2022
About Market Research Reports, Inc.
Market Research Reports provides a customized set
of reports from reputed Publishers, built on the
intelligence available within organizations and
leverages on our motto of “Intelligence Redefined”.
Contact : Amitava Sen
Email : info@marketresearchreports.com
Phone: +1 302-703-7787 (USA) +91-8762746600 (India)
www.MarketResearchReports.com